Cognition Therapeutics Inc (CGTX)
0.648
+0.03
(+5.54%)
USD |
NASDAQ |
Dec 24, 16:00
Cognition Therapeutics Free Cash Flow: -25.58M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| MetaVia Inc | -22.69M |
| Dermata Therapeutics Inc | -9.397M |
| ZyVersa Therapeutics Inc | -9.122M |
| Merck & Co Inc | 14.84B |
| NovaBay Pharmaceuticals Inc | -4.812M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.851M |
| Cash from Financing (Quarterly) | 0.329M |
| Free Cash Flow Per Share (Quarterly) | -0.1695 |
| Free Cash Flow Yield | -108.7% |